Understanding Polycystic Ovary Syndrome (PCOS)
Polycystic Ovary Syndrome (PCOS) is a complex endocrine and metabolic condition that affects many aspects of a woman’s health. It is typically characterised by a cluster of symptoms that may occur individually or together, including anovulation, infertility, insulin resistance, weight gain, acne, excess hair growth (hirsutism), and polycystic ovarian morphology.
However, symptoms that resemble PCOS may sometimes be linked to other underlying conditions that require further investigation and careful evaluation.
PCOS is not caused by a single factor. Rather, it often develops through a combination of genetic, metabolic, environmental, and lifestyle influences.
Factors that may increase the likelihood of developing PCOS include:
Nutritional deficiencies or dietary patterns that affect metabolic health
Exposure to environmental pollutants and hormone-disrupting chemicals
Chronic stress and impaired stress response (HPA axis dysregulation)
Insufficient or poor-quality sleep
Gut microbiome imbalances and increased intestinal permeability (“leaky gut”)
Infections or chronic inflammatory processes
Thyroid dysfunction
Impaired detoxification pathways
Mycotoxin exposure (mould)
Genetic predisposition
Obesity or metabolic dysfunction
These influences can contribute to a cascade of physiological changes, including hyperinsulinaemia, oxidative stress, chronic low-grade inflammation, elevated androgens, disrupted ovarian follicle development, and irregular menstrual cycles.
Your Body Is Communicating
“You are not alone, and there is hope. Your body is never working against you.”
PCOS can often feel like an emotional rollercoaster. Hormonal changes, uncertainty, and the physical symptoms themselves can create significant stress, which may further amplify the cycle.
From a functional medicine perspective, symptoms are not viewed as random or inconvenient problems to suppress. Instead, they are signals—your body’s way of communicating that something within the system needs attention.
When we begin to listen to those signals, we can start addressing the deeper imbalances that may be driving them.
PCOS Phenotypes: Every Woman Is Unique
PCOS does not present in the same way for everyone. Research increasingly recognises several phenotypes, or patterns, that reflect different underlying mechanisms.
These may overlap and evolve over time, which is why personalised assessment and treatment are essential.
Common PCOS phenotypes include:
Metabolic PCOS (insulin resistance-driven)
Inflammatory PCOS
Post-Pill PCOS
Adrenal PCOS
Lean PCOS
Understanding which patterns may be contributing to your symptoms allows treatment to be more targeted and effective.
Common Symptoms of PCOS
Physical symptoms
Irregular or absent menstrual cycles
Acne
Excess hair growth (hirsutism)
Weight gain or difficulty losing weight
Hair thinning or hair loss
Sleep disturbances
Mental and emotional symptoms
Mood swings
Anxiety
Low mood or depressive symptoms
Brain fog
Increased sensitivity to stress
A Functional Medicine Approach: Addressing the Root Cause
PCOS develops gradually and is influenced by many interconnected systems within the body. For this reason, a one-size-fits-all approach rarely leads to lasting change.
Instead, we take a personalised, root-cause approach that looks beyond symptom management.
Your healing journey begins with understanding your story = your health history, lifestyle, environment, and lived experiences. These pieces help reveal what may be contributing to your symptoms today.
At LITHE Health Clinic, this process may include:
Comprehensive health assessments
Advanced functional laboratory testing
In-depth interpretation of results
Nutritional therapy
Targeted supplement and nutraceutical protocols
Lifestyle and nervous system support
A supportive therapeutic partnership throughout your journey
Our goal is not simply to manage symptoms, but to restore communication and balance across the body’s systems.
By addressing the root drivers of imbalance, we aim to break cycles that medications or hormonal therapies alone may not fully resolve.
At LITHE Health Clinic, we view symptoms as meaningful signals - guiding us toward the areas that need nourishment, support, and care.
Polycystic Ovary Syndrome: Treatment & Care
– A Functional Medicine Approach to Healing from the Root
Ref.
1. Deswal R, Narwal V, Dang A, Pundir CS. The prevalence of polycystic ovary syndrome: a brief systematic review. J Hum Reprod Sci. 2020;13(4):261‑271. doi: 10.4103/jhrs.JHRS_95_18
2. Rao M, Broughton SK, LeMieux MJ. Cross-sectional study on the knowledge and prevalence of PCOS at a multiethnic university. Prev Med. 2020; e0028. doi: 10.1097/pp9.0000000000000028
3. Riestenberg C, Jagasia A, Markovic D, Buyalos RP, Azziz R. Health care-related economic burden of polycystic ovary syndrome in the United States: pregnancy-related and long-term health consequences. J Clin Endocrinol Metab. 2022;107(2):575‑585. doi: 10.1210/clinem/dgab613
4. Hoyos LR, Putra M, Armstrong AA, et al. Measures of patient dissatisfaction with health care in polycystic ovary syndrome: retrospective analysis. J Med Internet Res. 2020;22(4):e16541. doi: 10.2196/16541
5. Teede HJ, Tay CT, Laven JJE, et al. Recommendations from the 2023 International Evidence-Based Guideline for the Assessment and Management of Polycystic Ovary Syndrome. J Clin Endocrinol Metab.2023;108(10):2447‑2469. doi: 10.1210/clinem/dgad463
6. Sendur SN, Yildiz BO. Influence of ethnicity on different aspects of polycystic ovary syndrome: a systematic review. Reprod Biomed Online. 2021;42(4):799‑818. doi: 10.1016/j.rbmo.2020.12.006
7. Elghobashy M, Lau GM, Davitadze M, et al. Concerns and expectations in women with polycystic ovary syndrome vary across age and ethnicity: findings from PCOS Pearls Study. Front Endocrinol (Lausanne). 2023;14:1175548. doi: 10.3389/fendo.2023.1175548
8. Khatlani K, Njike V, Costales VC. Effect of lifestyle intervention on cardiometabolic risk factors in overweight and obese women with polycystic ovary syndrome: a systematic review and meta-analysis. Metab Syndr Relat Disord.2019;17(10):473‑485. doi: 10.1089/met.2019.0049
9. Abdolahian S, Tehrani FR, Amiri M, et al. Effect of lifestyle modifications on anthropometric, clinical, and biochemical parameters in adolescent girls with polycystic ovary syndrome: a systematic review and meta-analysis. BMC Endocr Disord. 2020;20(1):71. doi: 10.1186/s12902-020-00552-1
10. Aboeldalyl S, James C, Seyam E, Ibrahim EM, Shawki HE-D, Amer S. The role of chronic inflammation in polycystic ovarian syndrome-a systematic review and meta-analysis. Int J Mol Sci. 2021;22(5):2734. doi: 10.3390/ijms22052734
11. Abraham Gnanadass S, Divakar Prabhu Y, Valsala Gopalakrishnan A. Association of metabolic and inflammatory markers with polycystic ovarian syndrome (PCOS): an update. Arch Gynecol Obstet. 2021;303(3):631‑643. doi: 10.1007/s00404-020-05951-2
12. Kim KW. Unravelling polycystic ovary syndrome and its comorbidities. J Obes Metab Syndr. 2021;30(3):209‑221. doi: 10.7570/jomes21043
13. Wekker V, van Dammen L, Koning A, et al. Long-term cardiometabolic disease risk in women with PCOS: a systematic review and meta-analysis. Hum Reprod Update. 2020;26(6):942‑960. doi: 10.1093/humupd/dmaa029
14. Wang Y, Ni Z, Li K. The prevalence of anxiety and depression of different severity in women with polycystic ovary syndrome: a meta-analysis. Gynecol Endocrinol. 2021;37(12):1072‑1078. doi: 10.1080/09513590.2021.1942452
15. Fu L, Xie N, Qu F, Zhou J, Wang F. The association between polycystic ovary syndrome and metabolic syndrome in adolescents: a systematic review and meta-analysis. Reprod Sci. 2023;30(1):28‑40. doi: 10.1007/s43032-022-00864-8
16. Singh S, Pal N, Shubham S, et al. Polycystic ovary syndrome: etiology, current management, and future therapeutics. J Clin Med. 2023;12(4):1454. doi: 10.3390/jcm12041454
17. Kawa IA, Masood A, Fatima Q, et al. Endocrine disrupting chemical bisphenol A and its potential effects on female health. Diabetes Metab Syndr. 2021;15(3):803‑811. doi: 10.1016/j.dsx.2021.03.031
18. Zou Y, Liao R, Cheng R, Chung H, Zhu H, Huang Y. Alterations of gut microbiota biodiversity and relative abundance in women with PCOS: a systematic review and meta-analysis. Microb Pathog. 2023;184:106370. doi: 10.1016/j.micpath.2023.106370
19. Gu Y, Zhou G, Zhou F, et al. Gut and vaginal microbiomes in PCOS: implications for women's health. Front Endocrinol (Lausanne). 2022;13:808508. doi: 10.3389/fendo.2022.808508
20. Moslehi N, Zeraattalab-Motlagh S, Rahimi Sakak F, Shab-Bidar S, Tehrani FR, Mirmiran P. Effects of nutrition on metabolic and endocrine outcomes in women with polycystic ovary syndrome: an umbrella review of meta-analyses of randomized controlled trials. Nutr Rev. 2023;81(5):555‑577. doi: 10.1093/nutrit/nuac075
21. Di Lorenzo M, Cacciapuoti N, Lonardo MS, et al. Pathophysiology and nutritional approaches in polycystic ovary syndrome (PCOS): a comprehensive review. Curr Nutr Rep. 2023;12(3):527‑544. doi: 10.1007/s13668-023-00479-8
22. Menichini D, Ughetti C, Monari F, Di Vinci PL, Neri I, Facchinetti F. Nutraceuticals and polycystic ovary syndrome: a systematic review of the literature. Gynecol Endocrinol. 2022;38(8):623‑631. doi: 10.1080/09513590.2022.2089106
23. Hafizi Moori M, Nosratabadi S, Yazdi N, Kasraei R, Abbasi Senjedary Z, Hatami R. The effect of exercise on inflammatory markers in PCOS women: a systematic review and meta-analysis of randomized trials. Int J Clin Pract. 2023;2023:3924018. doi: 10.1155/2023/3924018
24. Dema H, Videtič Paska A, Kouter K, et al. Effects of mindfulness-based therapy on clinical symptoms and DNA methylation in patients with polycystic ovary syndrome and high metabolic risk. Curr Issues Mol Biol.2023;45(4):2717‑2737. doi: 10.3390/cimb45040178
25. Lim SS, Hutchison SK, Van Ryswyk E, Norman RJ, Teede HJ, Moran LJ. Lifestyle changes in women with polycystic ovary syndrome. Cochrane Database Syst Rev. 2019;3(3):CD007506. doi: 10.1002/14651858.CD007506.pub4
26. Patten RK, Pascoe MC, Moreno-Asso A, Boyle RA, Stepto NK, Parker AG. Effectiveness of exercise interventions on mental health and health-related quality of life in women with polycystic ovary syndrome: a systematic review. BMC Public Health. 2020;21(1):2310. doi: 10.1186/s12889-021-12280-9
27. Hu J, Shi W, Xu J, et al. Complementary and alternative medicine for the treatment of abnormal endometrial conditions in women with PCOS: a systematic review and meta-analysis of randomized controlled trials. Evid Based Complement Alternat Med. 2021;2021:5536849. doi: 10.1155/2021/5536849
28. Zheng R, Qing P, Han M, et al. The effect of acupuncture on glucose metabolism and lipid profiles in patients with PCOS: a systematic review and meta-analysis of randomized controlled trials. Evid Based Complement Alternat Med. 2021;2021:5555028. doi: 10.1155/2021/5555028